gc012f
gracell
['gc012f ', 'mmsm', 'car t']
phase 1 study of 28 patients treated with gc012f dual car t which binds bcma and cd19. rapid manufacturing delivers product to patients much faster, with rapid and durable responses with favorable tox profile. #mmsm #asco22 
Multiple Myeloma Research Foundation - Accelerating the development of next generation #myeloma treatments to extend patient’s lives, and lead to a cure.